LOS ANGELES — Kris Edwards waited at home with friends for his wife, Erika “Tilly” Edwards, to go out to dinner, but she never made it back to the house they had purchased only four days earlier. Around 9 p.m. on June 29, a hit-and-run driver killed Tilly as she walked to her car after…
Many healthcare executives are applauding the list of additional drugs chosen for the Medicare Drug Price Negotiation Program, while some drug companies are opposing it. The post How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program appeared first on MedCity News.
Merus brings Genmab a bispecific antibody in two pivotal studies for head and neck cancer. Genmab, which had long developed drugs under partnerships with larger companies, is now pursuing a strategy of developing and commercializing medications it fully owns. The post Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer…
Bristol Myers Squibb’s Cobenfy treats schizophrenia by going after a different target than currently available antipsychotic drugs, which is intended to offer better efficacy and safety. The drug came from the pharma giant’s $14 billion acquisition of Karuna Therapeutics. The post FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in…
Government documents viewed by KFF Health News show a drop in patients receiving care this year at the National Institutes of Health’s renowned research hospital, a 200-bed facility at NIH headquarters in Maryland. We previously reported a decrease in the number of patients being treated at the NIH Clinical Center from February through April. Since then,…
Natalie Schneider is CEO of Fort Health, a relatively new entrant into the children’s mental health market. Fort Health’s modus operandi is to partner with (i.e. market via) pediatricians to recruit patients. They are delivering integrated care and something called collaborative care…a newer model that has more frequent and shorter interventions and is more affordable….
The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production. The post Trump’s Push for U.S. Drug Manufacturing…
From the Peterson-KFF Health System Tracker: Most ACA Marketplace insurers are requesting premium increases in the 10-20% range for 2026. But more than a quarter (27%) of insurers are proposing premium increases of 20% or more for 2026. What individuals will pay for this insurance, however, is much higher because of the expiration of the…
This issue brief describes trends in health coverage in 2023, examines the characteristics of the uninsured population ages 0-64, and summarizes the access and financial implications of not having coverage.
Organizations that meet patients where they are financially, digitally, and emotionally are the ones best positioned to support patients in managing their bills while strengthening trust, satisfaction, and long-term loyalty. The post Meeting Patients Where They Are: A Smarter Path to Financial Health for Providers appeared first on MedCity News.